Bilakhia Holdings

Bilakhia Holdings is a diversified Indian investment group primarily recognized for its leadership in the global healthcare sector through its subsidiary, Meril Life Sciences. The company focuses on the innovation, design, and manufacturing of advanced medical devices, including cardiovascular technologies, orthopedic implants, and endosurgery tools. Its portfolio features breakthrough products such as the Myval transcatheter heart valve and the BioMime sirolimus-eluting stent. Operating from a massive manufacturing and R&D campus in Vapi, Gujarat, the group serves healthcare providers in over 100 countries. The group's entry into healthcare followed the successful divestment of their global printing ink business, Micro Inks, to the Huber Group.